EXEL 250117 15.00C (EXEL250117C15000) Stock Options, News & Quotes

20.05
+0.52+2.66%

15min DelayClose Jan 10 16:00 ET

20.25High19.97Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Ankur Modi

May 31, 2024 09:49

$Exelixis (EXEL.US)$ Something big coming next week , hold tight here

Moomoo AI

Feb 26, 2024 06:39

The market's opinion of the business has improved over the past year, as indicated by the share price increase outpacing EPS growth. Despite a 0.9% annual reduction in total shareholder return over five years, the business may be reversing its fortunes.

Exelixis' (NASDAQ:EXEL) 23% Return Outpaced the Company's Earnings Growth Over the Same One-year Period

Moomoo AI

Dec 27, 2023 06:45

The low P/S ratio indicates a bearish sentiment among Exelixis's shareholders, likely influenced by the company’s underwhelming revenue growth outlook. The current valuation suggests shareholders do not anticipate significant improvements enough to justify a higher P/S ratio.

Why Investors Shouldn't Be Surprised By Exelixis, Inc.'s (NASDAQ:EXEL) Low P/S

Moomoo AI

Dec 5, 2023 12:06

Selling of shares by insiders below current price can signal negativity to investors, though it's a weak sign. High insider ownership is positive but doesn't negate concerning share sales. Recent lack of insider transactions is seen as neutral.

19% Of This Exelixis Insider's Holdings Were Sold

Movers and Shakers

Apr 5, 2023 07:37

Columns Today's Pre-Market Stock Movers: PLTR, JNJ, ALB, FDX and More

Gapping up
$Johnson & Johnson (JNJ.US)$ +2.6% (The pharmaceutical giant announced Tuesday it will pay $8.9 billion over the next 25 years to settle claims that the talc in its baby powder and other products caused cancer. J&J also refiled for bankruptcy protection for its LTL Management subsidiary and said it continues to believe the claims lack merit.)
$Zions Bancorp (ZION.US)$ +3.2% (Baird upgraded the regional bank stock to an outper...